INIS
patients
100%
arthritis
89%
juveniles
59%
children
38%
diseases
35%
recommendations
23%
tumor necrosis factor
23%
blocking
22%
learning
21%
education
20%
pain
19%
glucocorticoids
18%
assessments
17%
management
16%
medicine
14%
teaching
14%
data
13%
comparative evaluations
12%
drugs
12%
range
11%
information
10%
feedback
10%
interventions
9%
pediatrics
9%
reviews
9%
cost
8%
investigations
8%
therapy
7%
adolescents
7%
adults
7%
Keyphrases
Systemic Juvenile Idiopathic Arthritis (sJIA)
54%
Etanercept
46%
Arthritis
44%
Dutch
44%
Professionalism
27%
Biological Agents
22%
Blocking Agent
22%
Rheumatoid Arthritis
22%
Tumor Necrosis Factor-α
22%
EULAR Recommendations
22%
Inactive Disease
15%
Intensive Care Medicine
14%
Spondyloarthritis
14%
General Practitioners
14%
Adalimumab
14%
Rheumatoid Arthritis Treatment
14%
Axial Spondyloarthritis (AxSpA)
13%
Everyday Practices
12%
Systematic Literature Review
12%
Unprofessional Behaviour
11%
Clinical Response
10%
Rheumatologists
10%
Treatment Efficacy
9%
Synthetic Disease-modifying Antirheumatic Drugs
9%
Literature Search
8%
Educational Intervention
8%
Professional Activity
8%
Etanercept Treatment
8%
Chronic Pain
7%
Medical Students
7%